Cleared Traditional

K200890 - Invacare Perfecto2V Oxygen Concentrator

K200890 is an FDA 510(k) clearance for Invacare Perfecto2V Oxygen Concentrator, manufactured by Invacare Corporation. The device is a Class 2 Anesthesiology device with product code CAW cleared through the Traditional 510(k) pathway after a 125-day FDA review.

K200890 · Invacare Corporation · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2020
Decision
125d
Days
Class 2
Risk

K200890 is an FDA 510(k) clearance for the Invacare Perfecto2V Oxygen Concentrator. Classified as Generator, Oxygen, Portable within the CAW classification (a category for home-use oxygen therapy and respiratory devices), Class II - Special Controls.

Submitted by Invacare Corporation (Elyria, US). The FDA issued a Cleared decision on August 6, 2020 after a review of 125 days - within the typical 510(k) review window.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5440 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Invacare Corporation devices

FDA 510(k) Submission Details - K200890

510(k) Number K200890 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 03, 2020
Decision Date August 06, 2020
Days to Decision 125 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
15d faster than avg
Panel avg: 140d · This submission: 125d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CAW Device Classification - Class 2, Special Controls

Product Code CAW Generator, Oxygen, Portable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CAW Generator, Oxygen, Portable

All 91
Devices cleared under the same product code (CAW) and FDA review panel - the closest regulatory comparables to K200890.
Oxygen Concentrator
K202389 · Foshan Mic Medical Technology Co., Ltd. · Apr 2022
Invacare Platinum 5NXG Oxygen Concentrator
K203210 · Invacare Corporation · Apr 2021
X-PLO2R
K203086 · Belluscura, LLC · Mar 2021
Aer X
K200496 · 3B Medical, Inc. · Jul 2020
Owgels Oxygen Concentrator
K191875 · Guangzhou Life Light Electronic Technology Co., Ltd. · Jul 2020
Nuvo Nano Portable Oxygen Concentrator
K192693 · Nidek Medical Products, Inc. · May 2020